Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$170.78 - $208.42 $9,905 - $12,088
58 Added 4.57%
1,327 $244,000
Q4 2023

Jan 09, 2024

SELL
$114.17 - $185.35 $9,932 - $16,125
-87 Reduced 6.42%
1,269 $228,000
Q3 2023

Oct 18, 2023

BUY
$138.78 - $176.51 $188,185 - $239,347
1,356 New
1,356 $215,000
Q1 2023

Apr 19, 2023

BUY
$154.26 - $198.1 $1,696 - $2,179
11 Added 0.87%
1,275 $214,000
Q4 2022

Feb 14, 2023

SELL
$162.42 - $220.56 $18,515 - $25,143
-114 Reduced 8.27%
1,264 $214,000
Q3 2022

Nov 07, 2022

SELL
$160.42 - $256.21 $36,896 - $58,928
-230 Reduced 14.3%
1,378 $258,000
Q2 2022

Aug 12, 2022

SELL
$140.68 - $188.02 $84,408 - $112,812
-600 Reduced 27.17%
1,608 $237,000
Q1 2022

Apr 29, 2022

SELL
$161.19 - $257.96 $8,704 - $13,929
-54 Reduced 2.39%
2,208 $415,000
Q4 2021

Feb 15, 2022

SELL
$247.59 - $304.47 $253,284 - $311,472
-1,023 Reduced 31.14%
2,262 $599,000
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $152,504 - $253,856
-783 Reduced 19.25%
3,285 $949,000
Q2 2021

Nov 12, 2021

BUY
$165.87 - $220.95 $11,610 - $15,466
70 Added 1.75%
4,068 $812,000
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $289,493 - $363,147
-1,605 Reduced 28.65%
3,998 $777,000
Q4 2020

Feb 18, 2021

BUY
$148.08 - $206.57 $315,854 - $440,613
2,133 Added 61.47%
5,603 $1.07 Million
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $388,356 - $501,715
3,170 Added 1056.67%
3,470 $512,000
Q1 2020

May 18, 2020

BUY
$84.96 - $109.14 $25,487 - $32,742
300 New
300 $29,000
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $15,506 - $19,546
-210 Closed
0 $0
Q3 2019

May 28, 2020

BUY
$76.65 - $95.51 $16,096 - $20,057
210 New
210 $16,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.